Skip to main content
. 2016 Feb 19;6:21483. doi: 10.1038/srep21483

Figure 4. The representative immunostaining results for DDX3, pDvl2, β-catenin expression in colorectal tumors and the prognostic value of these expressions on OS and RFS was assessed by Kaplan-Meier analysis.

Figure 4

(a) The representative immunostaining results of DDX3, pDvl2, and nuclear β-catenin in colorectal tumors; (b) The survival curves for overall survival (OS) and relapse free survival (RFS) in colorectal patients with high-DDX3, high-pDvl2, and high-nuclear β-catenin tumors were compared with those with low-DDX3, low-pDvl2, and low-nuclear β-catenin tumors.